Quick Answer
Harvard Apparatus Regenerative Technology, Inc. reported R&D Expense of $2.65 million for fiscal year 2025.
Harvard Apparatus Regenerative Technology, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $2.65M | +14.8% |
| 2024 | $2.31M | -24.6% |
| 2023 | $3.06M | +75.8% |
| 2022 | $1.74M | +9.4% |
| 2021 | $1.59M | -23.1% |
| 2020 | $2.07M | -57.4% |
| 2019 | $4.85M | +23.9% |
| 2018 | $3.92M | -48.4% |
| 2017 | $7.59M | -0.2% |
| 2016 | $7.60M | +58.9% |
| 2015 | $4.79M | -6.5% |
| 2014 | $5.12M | +12.2% |
| 2013 | $4.56M | +13.3% |
| 2012 | $4.03M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $655.0K | +17.6% | -6.0% |
| June 30, 2025 | $697.0K | +8.6% | +16.0% |
| March 31, 2025 | $601.0K | -28.5% | +7.9% |
| September 30, 2024 | $557.0K | +64.3% | -13.2% |
| June 30, 2024 | $642.0K | -59.0% | -23.6% |
| March 31, 2024 | $840.0K | +65.0% | +147.8% |
| September 30, 2023 | $339.0K | -8.1% | -78.4% |
| June 30, 2023 | $1.57M | +380.4% | +207.7% |
- Harvard Apparatus Regenerative Technology, Inc. showed an increase of +14.8% in R&D Expense compared to the prior fiscal year.
- Over the 2012–2025 period, Harvard Apparatus Regenerative Technology, Inc.’s r&d expense has declined by 34.1% (from $4.03 million to $2.65 million).
- The most recent figure is from Harvard Apparatus Regenerative Technology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: